Web Exclusives

Treatment guidelines for pediatric Hodgkin lymphoma issued by the International Lymphoma Radiation Oncology Group (ILROG)

The International Lymphoma Radiation Oncology Group (ILROG) has issued a guideline outlining use of 3-D computed tomography (CT)-based radiation therapy planning.

Genetically engineered immunotoxin shows early promise for B-cell malignancies

DT2219, a new bispecific ligand-directed diphtheria toxin, was found to be effective in a small group of patients with relapsed/refractory B-cell malignancies, according to clinical trial results.

Scent-trained dog detects thyroid cancer in human urine samples

A canine trained to identify cancer in urine samples by scent was able to differentiate thyroid cancer from benign status nearly 90 percent of the time.

Risk of breast cancer in transgender persons studied in veterans

A study of breast cancer in transgender veterans has identified 10 new cases, increases the number of recorded cases in transgender individuals.

Chromosomal rearrangement is key to progress against aggressive infant leukemia

Current research indicates that a rare but aggressive subtype of pediatric acute lymphoblastic leukemia (ALL) has surprisingly few mutations beyond the chromosomal rearrangement that affects the MLL gene.

Risk of thyroid cancer increases after a breast cancer diagnosis

Risk of thyroid cancer increases after a breast cancer diagnosis

Breast cancer survivors have a higher risk of developing thyroid cancer, especially within 5 years of their breast cancer diagnosis, according to a national database analysis.

African American cancer patients' depression symptoms often under-recognized

Depressed African American patients with cancer could be more accurately identified if the depression measures used are more culturally sensitive, according to a study.

Advanced thyroid cancer responds to targeted therapy with sunitinib

Sunitinib (Sutent), a drug approved for treatment of several other cancers, may be an effective adjunctive treatment for patients with advanced differentiated thyroid cancer.

Fifteen new breast cancer genetic risk 'hot-spots' revealed

Fifteen new breast cancer genetic risk 'hot-spots' revealed

Researchers compared tiny variations in the genetic make-up of more than 120,000 women of European ancestry, with and without breast cancer, and identified 15 new genetic variations linked to a higher risk of the disease.

April Contest

Click here to get started

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs